Q2 EPS Estimate for Procter & Gamble Decreased by Analyst

Procter & Gamble Company (The) (NYSE:PG – Free Report) – Investment analysts at Zacks Research cut their Q2 2027 earnings per share estimates for Procter & Gamble in a research report issued on Thursday, November 5th. Zacks Research analyst Team now expects that the company will post earnings of $1.80 per share for the quarter, down from their previous estimate of $1.88. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.99 per share. Zacks Research also issued estimates for Procter & Gamble’s Q3 2027 earnings at $1.63 EPS, Q4 2027 earnings at $1.53 EPS, FY2027 earnings at $6.96 EPS, Q1 2028 earnings at $2.11 EPS, Q2 2028 earnings at $1.98 EPS, Q3 2028 earnings at $1.73 EPS, Q4 2028 earnings at $1.59 EPS, FY2028 earnings at $7.41 EPS, Q1 2029 earnings at $2.25 EPS and FY2029 earnings at $7.91 EPS.

Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The firm had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. During the same quarter in the prior year, the business earned $1.99 earnings per share. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year.

Several other equities analysts also recently commented on PG. Citigroup increased their price objective on shares of Procter & Gamble from $180.00 to $187.00 and gave the company a “buy” rating in a research note on Friday, October 23rd. HSBC cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and decreased their target price for the stock from $182.00 to $149.00 in a research note on Thursday, July 30th. Bank of America lowered their price target on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a report on Friday, July 10th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Procter & Gamble in a research note on Friday, October 23rd. Finally, Argus downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a report on Friday, August 7th. Fifteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $170.57.

Read Our Latest Research Report on PG

Procter & Gamble Trading Down 0.1%

Shares of Procter & Gamble stock opened at $167.15 on Friday. The firm’s 50 day moving average is $151.56 and its 200 day moving average is $149.34. The firm has a market capitalization of $387.41 billion, a PE ratio of 25.17, a price-to-earnings-growth ratio of 4.11 and a beta of 0.36. Procter & Gamble has a 1 year low of $137.62 and a 1 year high of $170.52. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40.

Institutional Trading of Procter & Gamble

Institutional investors have recently modified their holdings of the business. BlackRock Inc. bought a new stake in Procter & Gamble in the second quarter valued at approximately $27,862,105,000. State Street Corp raised its holdings in Procter & Gamble by 1.0% during the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after purchasing an additional 965,461 shares during the last quarter. Bank of America Corp DE bought a new position in Procter & Gamble during the 2nd quarter worth approximately $3,850,628,000. Bank of New York Mellon Corp bought a new position in Procter & Gamble during the 2nd quarter worth approximately $2,281,505,000. Finally, Dimensional Fund Advisors LP lifted its position in shares of Procter & Gamble by 2.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock worth $1,704,182,000 after purchasing an additional 300,280 shares during the period. Institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In related news, CAO Matthew Janzaruk sold 9,479 shares of the firm’s stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $163.00, for a total value of $1,545,077.00. Following the completion of the transaction, the chief accounting officer owned 1,271 shares in the company, valued at $207,173. This trade represents a 88.18% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 33,624 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $165.00, for a total transaction of $5,547,960.00. Following the sale, the chief financial officer owned 65,618 shares in the company, valued at approximately $10,826,970. This represents a 33.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 161,709 shares of company stock valued at $26,244,058 over the last three months. Insiders own 0.23% of the company’s stock.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.6%. Procter & Gamble’s dividend payout ratio is currently 65.51%.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Zacks Research raised its FY2029 EPS estimate to $7.91 from $7.85 and lifted its Q1 2028 and Q1 2029 forecasts. The longer-term increases provide a modest positive counterpoint to reductions in other periods.
  • Positive Sentiment: P&G’s latest reported quarter beat analyst expectations for earnings and revenue, with sales up 4% year over year. Demand for dependable dividend-paying consumer-staples stocks has also supported interest in the shares.
  • Neutral Sentiment: P&G will webcast its November 19 Investor Day, where executives are expected to discuss strategy and the company’s long-term transformation. Investors may look for updates on growth plans and execution. Article: P&G Investor Day webcast
  • Negative Sentiment: Zacks Research trimmed several nearer-term estimates, including FY2027 EPS to $6.96 from $6.97 and FY2028 to $7.41 from $7.42; multiple quarterly forecasts for 2027–28 were also reduced. The small cuts suggest somewhat softer expectations for those periods.
  • Negative Sentiment: CFO Andre Schulten sold 33,624 shares for about $5.55 million, reducing his direct holding by roughly 34%. Insider sales can weigh on sentiment, though they do not necessarily indicate a change in the company’s outlook. Article: CFO share sale

About Procter & Gamble

(Get Free Report)

Featured Stories

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.